OCT 01, 2020 7:00 AM PDT

Immune Cells and MS: The Good, the Bad, and the Maybe

WRITTEN BY: Tara Fernandes

Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a similar layer called myelin. This lipid-rich outer shell is instrumental in helping nerve cells transmit messages via electrical impulses. In patients with multiple sclerosis, or MS, their immune systems go rogue, attacking the myelin sheaths of nerve cells with devastating effects: blindness, a loss of coordination, muscle weakness, and even psychiatric problems.

A study by researchers at the University of California has brought to light how a particular subset of immune cells called regulatory T cells, or T regs, shield against the autoimmune attack of the spinal cord in conditions such as MS.

Previously, the team found that cells responsible for the destruction of nervous tissues in MS were Th17 cells. Though destructive, Th17 cells were not unstoppable. The researchers found that T regs had the power to dampen the activity of Th17 cells, even resulting in partial recovery from MS-induced paralysis. This was a major breakthrough in the field, suggesting that immunotherapies could be a promising means of helping patients with MS.

"We discovered a unique 'repetitive scanning motility' by which Treg cells (the good guys) dampen calcium signaling in pathogenic Th17 cells (the bad guys), and help to resolve neuroinflammation and limit reactivation of Th17 cells in the spinal cord," said UCI scientist and lead author of the study, Shivashankar Othy.

Michael D. Cahalan, the senior author of the publication, published in the Proceedings of the National Academy of Sciences also said, "Building on our years of expertise in immunoimaging and calcium signaling, this study highlights Th17 and Treg cell interactions, their motility characteristics, and intracellular signaling, thus providing new insights into the pathophysiology of MS. Our results illustrate how a regulatory T cell-based immunotherapy may be instrumental in limiting demyelination in MS."

 

Sources: Proceedings of the National Academy of Sciences, Science Daily


 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 06, 2022
Health & Medicine
COVID-19 Nasal Spray Vaccines in the Making
FEB 06, 2022
COVID-19 Nasal Spray Vaccines in the Making
Bharat Biotech, a biotechnology company in India, is expected to be the first to offer a COVID-19 nasal spray vaccine wi ...
FEB 26, 2022
Health & Medicine
Vitamin D Deficiency Linked to Increased Risk of COVID Infection and More Severe Symptoms
FEB 26, 2022
Vitamin D Deficiency Linked to Increased Risk of COVID Infection and More Severe Symptoms
A century ago before effective antibiotics were available, tuberculosis patients were placed outside on sunny days becau ...
APR 20, 2022
Cancer
A Specialized Mouse Model Identifies Genetic Regulators of Immunotherapy Response
APR 20, 2022
A Specialized Mouse Model Identifies Genetic Regulators of Immunotherapy Response
Recent advances in immune checkpoint inhibitors (ICI) have led to significant clinical benefits for patients with variou ...
APR 27, 2022
Clinical & Molecular DX
Asthma Risk Increased in Children Conceived with Infertility Treatment
APR 27, 2022
Asthma Risk Increased in Children Conceived with Infertility Treatment
Asthma is a disease characterized by difficulty breathing, and an asthma attack can bring on bouts of coughing and wheez ...
APR 29, 2022
Immunology
Mental Health and Our Immune System
APR 29, 2022
Mental Health and Our Immune System
The conversation regarding mental health is finally at the forefront and is no longer a taboo topic that people shy away ...
APR 28, 2022
Immunology
Lipid Supplement May Reduce Inflammation in MS
APR 28, 2022
Lipid Supplement May Reduce Inflammation in MS
Administration of an inflammation-mediating lipid has shown promise in reducing multiple sclerosis-related inflammation ...
Loading Comments...